Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
566 participants
INTERVENTIONAL
2012-01-31
2017-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
motivational intervention
7-session individual motivationally-based intervention
motivational intervention
7-session individual motivationally-based intervention
health education
7-session individual session focusing on health education
health education
7 individual sessions focusing on health education
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
motivational intervention
7-session individual motivationally-based intervention
health education
7 individual sessions focusing on health education
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Binge drink (5 or more drinks in a 2-hour period for men, 4 or more for women) at least monthly
* Use marijuana at least weekly
* Have been heterosexually active in the past six months
* Are not married
* Have not been living with a sexual or romantic partner for more than 6 months
* Be English speaking
* Reside within 20 miles of Providence, RI and plans to stay in the geographic area for the next 15 months
* Provide contact information for at least two verifiable locator persons
Exclusion Criteria
* Have DSM-IV diagnosis of alcohol dependence
18 Years
25 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Butler Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Michael Stein, MD
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael D Stein, MD
Role: PRINCIPAL_INVESTIGATOR
Butler Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Butler Hospital
Providence, Rhode Island, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Caviness CM, Anderson BJ, Stein MD. Impact of Nicotine and Other Stimulants on Sleep in Young Adults. J Addict Med. 2019 May/Jun;13(3):209-214. doi: 10.1097/ADM.0000000000000481.
Caviness CM, Anderson BJ, Stein MD. Energy drinks and alcohol-related risk among young adults. Subst Abus. 2017 Oct-Dec;38(4):376-381. doi: 10.1080/08897077.2017.1343217. Epub 2017 Jun 16.
Moitra E, Christopher PP, Anderson BJ, Stein MD. Coping-motivated marijuana use correlates with DSM-5 cannabis use disorder and psychological distress among emerging adults. Psychol Addict Behav. 2015 Sep;29(3):627-32. doi: 10.1037/adb0000083. Epub 2015 Apr 27.
Caviness CM, Tzilos G, Anderson BJ, Stein MD. Synthetic Cannabinoids: Use and Predictors in a Community Sample of Young Adults. Subst Abus. 2015;36(3):368-73. doi: 10.1080/08897077.2014.959151. Epub 2014 Sep 15.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.